CD274 and neoplasm: Our study confirms the capability of the LIPI score to successfully stratify patients with solid tumors treated with anti-PD1/PD-L1 in different prognostic subgroups, independently from all main clinicopathological characteristics, in a tumor-agnostic fashion, both in terms of PFS and OS.